pSivida
EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
| Public company | |
| Traded as | NASDAQ: PSDV ASX: PVA FWB: PV3 |
| Industry | Pharmaceuticals |
| Headquarters | , |
Number of locations | 2 |
| Products | Iluvien |
| Website | www |
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner..In April 2018, pSivida purchased eye products firm Icon Bioscience.[1]
See also
- Alimera Sciences, pSvida's partner on Iluvien
References
- Letter, The Pharma. "BRIEF—pSivida to buy eye products firm Icon Bioscience". www.thepharmaletter.com. Retrieved 2018-06-22.
External links
- Official website
- "pSivida (PSDV) Enters Two Funded Evaluation Agreements with Leading Pharma". StreetInsider.com. May 12, 2015. Retrieved May 15, 2015.
- Lindon, Hal (May 5, 2014). "UPDATE: pSivida Issues Presentation of Preclinical Data Showing Sustained Release of Avastin Using Tethadur". Benzinga. Retrieved May 15, 2015.
pSivida's Dinesh K. Nadarassan presented a poster entitled “Sustained Release of Bevacizumab (Avastin) from BioSilicon”
- pSivida Mesoporous silicon patent
| Divisions and subsidiaries |
| ||||
|---|---|---|---|---|---|
| Shareholdings and partnerships | |||||
| Products |
| ||||
| Places and vessels | |||||
| Predecessors | |||||
| People | |||||
 | |||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.